Trials / Withdrawn
WithdrawnNCT04347135
Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI
Pilot Study Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Annie (Annie) T. Packard · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Researchers are trying to improve the detection of endometriosis using F-18 FES PET/MRI imaging.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | F-18 FES | F-18 FES PET/MRI for detection of endometriosis. |
Timeline
- Start date
- 2022-10-07
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
- First posted
- 2020-04-15
- Last updated
- 2024-05-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04347135. Inclusion in this directory is not an endorsement.